WHO: Swine flu vaccine on track

Aug 06, 2009 By MARIA CHENG , AP Medical Writer

(AP) -- Swine flu vaccine manufacturers are on track to start delivering the first batches of it in September, the World Health Organization said Thursday.

Marie-Paule Kieny, WHO's vaccine director, said several drug makers have started testing in humans, and that early safety results should be available next month, clearing the way for its use. Kieny also insisted that speeding the vaccine to the market will not compromise its safety.

WHO has recommended the first recipients of the vaccine be health care workers, perhaps followed by pregnant women and people with underlying health problems.

Kieny said WHO expects to see reports of side effects once the vaccine is given to millions of people, but that deadly side effects will be rare. Vaccines commonly provoke reactions such as nausea, fever, pain from the injection, and diarrhea.

She said the agency would work with country officials to detect any sign the vaccine might cause more worrying side effects, like Guillain Barre syndrome, a temporary paralysis disorder reported by hundreds of people after the U.S.'s disastrous 1976 immunization campaign against another variant of swine flu.

To fight the current pandemic , or global outbreak, half a dozen major pharmaceutical companies located in the United States, Europe and Australia are developing their own swine flu vaccines, which will have to be approved by drug regulatory authorities in each country where they are used.

It is the first time that companies have rushed to produce a vaccine within months to fight a flu pandemic. Health officials expect swine flu to surge in the fall, with the return of the regular .

On Wednesday, Swiss drug maker Novartis said it had begun testing its swine flu vaccine in Europe, and would begin selling it long before completing its safety tests next year.

Last month, Australian pharmaceutical CSL started trials on its .

Kieny said ongoing tests in Australia, China, Germany, the United Kingdom and the United States should inform officials how many doses of the vaccine are required. Many experts think people will need two shots to be protected.

Europe and the U.S. both have fast-track approval systems to make the swine flu vaccine available before extensive safety tests are completed.

In a statement on its Web site, WHO said Thursday "the public needs to be reassured" that procedures for approving swine flu vaccines "are rigorous and do not compromise safety or quality controls."

To increase the global supply of vaccines, WHO recommends that countries use ones containing adjuvants, a component that stretches the vaccine's active ingredient and boosts the body's immune response. Adjuvants are commonly used in flu vaccines in Europe, but there are no licensed flu vaccines with adjuvants in the U.S.

There is little or no information on how safe flu vaccines with adjuvants are in pregnant women and children - two of the groups most at risk in the pandemic.

Kieny dismissed concerns adjuvanted vaccines might not be ideal for groups such as pregnant women. "We see no apparent safety signal," she said. "There is no safety concern with using adjuvanted vaccine."

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: App for headache sufferers shows success

add to favorites email to friend print save as pdf

Related Stories

Novartis starts testing swine flu vaccine

Aug 05, 2009

(AP) -- Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday. The vaccine is being tested in a yearlong trial of 6,000 ...

GlaxoSmithKline taking pandemic vaccine orders

May 15, 2009

(AP) -- Pharmaceutical giant GlaxoSmithKline said Friday it has received orders from several countries to stockpile pandemic vaccine as soon as it gets the vaccine's key ingredient from the World Health Organization.

Australia starts 1st swine flu vaccine trials

Jul 22, 2009

(AP) -- The world's first human trials of a swine flu vaccine have begun in Australia, drug company officials said Wednesday, with the aim of controlling the virus that has so far killed more than 700 worldwide.

US wants ingredient in swine flu vaccine by May

Apr 28, 2009

(AP) -- U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, but tell The Associated Press that the novel virus grows slowly in eggs - the chief way flu vaccines are made.

Europe fast-tracking swine flu vaccine

Jul 26, 2009

(AP) -- In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a new flu vaccine, arousing concern among some experts about safety ...

WHO meets on production of swine flu vaccine

May 14, 2009

(AP) -- As swine flu cases hit 6,500 worldwide, World Health Organization officials were meeting with vaccine manufacturers and other experts in Geneva on Thursday to discuss making a vaccine to fight the virus.

Recommended for you

Fatigue, fear are daily lot of Ebola fighters: experts

4 hours ago

Doctors, nurses and hospital workers fighting the Ebola epidemic in west Africa are struggling with a daily burden of exhaustion, shortage of staff and fear for themselves over the deadly virus, specialists say.

Hong Kong makes Ebola 'contingency' measures

7 hours ago

Hong Kong said Wednesday it was quarantining all people from Guinea, Sierra Leone and Liberia who were showing Ebola-like symptoms on arrival in the city, as fears grow worldwide about the spread of the deadly virus.

User comments : 0